Clinical Trial Update: Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing solifenacin with oxybutynin for overactive bladder; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (Vesicare) (solifenacin)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2010-01-11